Banque Transatlantique SA Buys Shares of 1,299 Cigna Group $CI

Key Points

• Banque Transatlantique SA acquired 1,299 shares of Cigna Group, valued at approximately $395,000, as part of their new investment position in the 1st quarter.
• Cigna Group reported a strong quarterly performance with earnings of $7.20 per share, exceeding analyst expectations, and revenue of $67.13 billion, representing an 11% year-over-year increase.
• The company announced a quarterly dividend of $1.51 per share, translating to an annualized yield of 2.0%, with the dividend set to be paid on September 18th.

Banque Transatlantique SA bought a new stake in shares of Cigna Group (NYSE:CI - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The fund bought 1,299 shares of the health services provider's stock, valued at approximately $395,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD raised its stake in Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider's stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Cigna Group by 0.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider's stock valued at $3,834,493,000 after purchasing an additional 98,715 shares during the period. Dodge & Cox raised its stake in shares of Cigna Group by 1.3% in the 1st quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider's stock worth $2,924,722,000 after buying an additional 117,125 shares in the last quarter. GQG Partners LLC raised its stake in shares of Cigna Group by 21.5% in the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock worth $1,607,716,000 after buying an additional 865,092 shares in the last quarter. Finally, Parnassus Investments LLC lifted its holdings in shares of Cigna Group by 3.1% in the first quarter. Parnassus Investments LLC now owns 2,885,583 shares of the health services provider's stock valued at $949,357,000 after buying an additional 86,602 shares during the period. Institutional investors own 86.99% of the company's stock.

Cigna Group Trading Up 0.7%

Cigna Group stock traded up $2.04 during midday trading on Tuesday, reaching $302.93. The stock had a trading volume of 422,786 shares, compared to its average volume of 1,818,616. The firm's fifty day simple moving average is $297.09 and its two-hundred day simple moving average is $312.18. Cigna Group has a twelve month low of $256.89 and a twelve month high of $370.83. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market cap of $80.86 billion, a price-to-earnings ratio of 16.55, a PEG ratio of 0.89 and a beta of 0.48.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping the consensus estimate of $7.15 by $0.05. The firm had revenue of $67.13 billion for the quarter, compared to analysts' expectations of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company's quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be paid a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Thursday, September 4th. Cigna Group's dividend payout ratio is currently 32.97%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on CI. Wall Street Zen lowered Cigna Group from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a research report on Monday, June 23rd. Guggenheim reiterated a "buy" rating and issued a $350.00 target price (down from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Barclays increased their target price on shares of Cigna Group from $354.00 to $383.00 and gave the company an "overweight" rating in a research note on Thursday, September 4th. Finally, Robert W. Baird set a $372.00 price target on Cigna Group in a report on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, Cigna Group has a consensus rating of "Buy" and an average target price of $374.76.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares of the company's stock, valued at $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.70% of the company's stock.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.